FDA Approves Previously Rejected Muscular Dystrophy Treatment
FDA Approves Previously Rejected Muscular Dystrophy Treatment
The drug Vyondys 53 has met a surrogate endpoint of protein production, but there’s no clear proof it has a clinical benefit.
FDA Approves Previously Rejected Muscular Dystrophy Treatment
FDA Approves Previously Rejected Muscular Dystrophy Treatment

The drug Vyondys 53 has met a surrogate endpoint of protein production, but there’s no clear proof it has a clinical benefit.

The drug Vyondys 53 has met a surrogate endpoint of protein production, but there’s no clear proof it has a clinical benefit.

FDA
Former FDA Commissioner Frank Young Dies
Former FDA Commissioner Frank Young Dies
Jef Akst | Dec 2, 2019
The physician-researcher laid the groundwork for genetic cloning and led the US Food and Drug Administration as the country faced the AIDS crisis in the 1980s.
Ebola Vaccine Approved for Use in Europe
Ebola Vaccine Approved for Use in Europe
Jef Akst | Nov 11, 2019
Merck’s Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months.
Trump Picks Cancer Researcher Stephen Hahn for FDA Commissioner
Trump Picks Cancer Researcher Stephen Hahn for FDA Commissioner
Emily Makowski | Nov 4, 2019
The radiation oncologist and chief medical executive at MD Anderson Cancer Center has not worked in government previously.
FDA Approves New Cystic Fibrosis Drug
FDA Approves New Cystic Fibrosis Drug
Shawna Williams | Oct 24, 2019
The treatment, Trikafta, increases lung function in most patients with the disease—but comes with a hefty price tag.
The Cerebellum’s Secrets: A Profile of Kamran Khodakhah
The Cerebellum’s Secrets: A Profile of Kamran Khodakhah
Anna Azvolinsky | Oct 1, 2019
The Albert Einstein College of Medicine neuroscientist has revealed surprising functions of the brain region, such as its role in the brain’s rewards circuits and in addiction.
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Antidepressant Approvals Could Herald New Era in Psychiatric Drugs
Bianca Nogrady | Oct 1, 2019
The FDA has given the green light to the first major new classes of antidepressant therapies in decades, opening up new avenues for therapeutic development.
EPA Aims to Drastically Reduce Animal Testing
EPA Aims to Drastically Reduce Animal Testing
Emily Makowski | Sep 11, 2019
The agency plans to stop funding virtually all toxicology studies in mammals by 2035.
UCSD Eye Doctor Resigns After Investigation into Ties with ChinaUCSD Eye Doctor Resigns After Investigation into Ties with China
UCSD Eye Doctor Resigns After Investigation into Ties with China
Nicoletta Lanese | Aug 23, 2019
The FDA and the university have audited Kang Zhang for breaches in bioethics and a failure to follow research protocols.
First New Tuberculosis Drug Approved in 50 Years
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.